Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Venrock Healthcare Capital Partners III, L.P. reported a 9.40% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Venrock Healthcare Capital Partners III, L.P. reported a 9.40% stake in Cytomx Therapeutics, Inc., 15,561,500 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 15,561,500
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 9.40% | 15,561,500 |
| VHCP Co-Investment Holdings III, LLC | 9.40% | 15,561,500 |
| Venrock Healthcare Capital Partners EG, L.P. | 9.40% | 15,561,500 |
| VHCP Management III, LLC | 9.40% | 15,561,500 |
| VHCP Management EG, LLC | 9.40% | 15,561,500 |
| Nimish Shah | 9.40% | 15,561,500 |
| Bong Y. Koh | 9.40% | 15,561,500 |
Source
Related
- Cytomx Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · May 20, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026